Cancer and Interval and Continuous Exercise Training

Not Applicable

• Conditions: Axillary tail of breast; Breast cancer.

• Registration Number: IRCT2016040327194N1
• Lead Sponsor: Researcher

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 45

Inclusion Criteria

Gender ( Female ), The participants are currently undergoing drug therapy(Tamoxifen); In the last 6 months have not participated in any regular exercise program; myocardial infarction, arrhythmias uncontrolled and extreme pressure (treated), do not have. Exclusion criteria:
Absence of more than 2 sessions of 18 session; Recognition of the need to exclude health; personal desire to withdraw from the study; susceptibility to other diseases; accidents and the factors that cause the participants can participate in training sessions.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Malondialdehyde. Timepoint: Before and after 6 weeks exercise. Method of measurement: Using an ELISA kit.;Toal antioxidant capacity. Timepoint: Before and after 6 weeks exercise. Method of measurement: Using an ELISA kit.;Aerobic power. Timepoint: Before and after 6 weeks exercise. Method of measurement: Formula.

Secondary Outcome Measures

Name	Time	Method
Body fat percentage, Functional capacity. Timepoint: Before and after 6 weeks exercise. Method of measurement: Using calipers-formula Jackson, Test 6MWT.